BRIEF-JBT Corporation Shareholders Approve Combination With Marel HF-March 2024-www.financetom.com

BRIEF-JBT Corporation Shareholders Approve Combination With Marel HF

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-JBT Corporation Shareholders Approve Combination With Marel HF

Aug 8, 2024 3:42 PM

Aug 8 (Reuters) - John Bean Technologies Corp ( JBT ):

* JBT CORPORATION SHAREHOLDERS APPROVE COMBINATION WITH

MAREL HF.

* JOHN BEAN TECHNOLOGIES CORP ( JBT ) - MAREL TAKEOVER OFFER EXPIRES

SEPTEMBER 2, 2024

Source text for Eikon:

Further company coverage:

Previous page： Google agrees $36 million fine for anti-competitive deals with Australia telcos Next page： Chemours, DuPont, Corteva to Pay $875 Million to Resolve New Jersey Contamination Claims

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Google agrees $36 million fine for anti-competitive deals with Australia telcos

Aug 17, 2025

SYDNEY, Aug 18 (Reuters) - Google agreed on Monday to pay a A$55 million ($35.8 million) fine in Australia after the consumer watchdog found it had hurt competition by paying the country's two largest telcos to pre-install its search application on Android phones, excluding rival search engines. The fine extends a bumpy period for the Alphabet-owned internet giant in Australia,...

Chemours, DuPont, Corteva to Pay $875 Million to Resolve New Jersey Contamination Claims

Aug 4, 2025

07:45 AM EDT, 08/04/2025 (MT Newswires) -- Chemours ( CC ) , DuPont ( DD ) and Corteva ( CTVA ) said Monday they have agreed to pay $875 million to the state of New Jersey to resolve pending environmental contamination claims. The settlement payments will be made over a 25-year period starting within 30 days after the entry of...

BRIEF-XOMA Royalty to acquire LAVA Therapeutics for $1.16-$1.24 per share

Aug 4, 2025

Aug 4 (Reuters) - LAVA Therapeutics NV ( LVTX ): * XOMA ROYALTY ENTERS INTO AGREEMENT TO ACQUIRE LAVA THERAPEUTICS FOR BETWEEN $1.16 AND $1.24 PER SHARE IN CASH, PLUS A CONTINGENT VALUE RIGHT * XOMA ROYALTY CORP ( XOMA ) - ACQUISITION INCLUDES CVR FOR 75% OF NET PROCEEDS * XOMA ROYALTY CORP ( XOMA ) - TO COMMENCE...

Crypto firm Bullish aims to raise up to $629 million in US IPO

Aug 4, 2025

Aug 4 (Reuters) - Bullish is aiming to raise up to $629.3 million in its U.S. IPO, the crypto company said in a filing on Monday. ...